AAA817
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for AAA817, covering 2026-02-24 to 2026-04-16. Get the full timeline:
Most recent: Clinical Trial Update: Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy [Phase 2, Phase 3]